Svoboda
|
Graniru
|
BBC Russia
|
Golosameriki
|
Facebook
Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europe
Asia
Tech
AI
Finance
Personal Finance
Real Estate
Crypto
Leadership
Success
Well
Life
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Education
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Business Solutions
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Fortune Company List
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
Michelle Fay Cortez
Health
COVID still kills 1 person every 4 minutes despite the global emergency being officially over
BY
Michelle Fay Cortez
and
Bloomberg
Health
Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease
BY
Michelle Fay Cortez
and
Bloomberg
Health
T cells fight off severe Omicron, says a new Dutch and South African study
BY
Marthe Fourcade
,
Michelle Fay Cortez
, and others
Health
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
BY
Michelle Fay Cortez
and
Bloomberg
Health
Moderna’s CEO believes new COVID vaccines are likely needed to protect against the Omicron variant
BY
Michelle Fay Cortez
and
Bloomberg
International
A viral video of government workers killing a corgi is terrifying China’s pet owners
BY
Jenni Marsh
,
Michelle Fay Cortez
, and others
Health
Those with previous COVID infections may be less likely to catch Delta than those vaccinated with Pfizer
BY
Michelle Fay Cortez
and
Bloomberg
International
A silver lining for places low on vaccines: a delayed second dose may provide stronger immunity
BY
Michelle Fay Cortez
and
Bloomberg
International
For ‘COVID Zero’ success stories, opening up is hard to do
BY
Michelle Fay Cortez
,
Jinshan Hong
, and others
International
AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data
BY
James Paton
,
Michelle Fay Cortez
, and others
Health
AstraZeneca’s U.S. COVID trial in doubt after agency says drugmaker may have submitted outdated data
BY
Michelle Fay Cortez
,
Jason Gale
, and others
Health
A faster-spreading COVID variant puts a spotlight on the U.S. vaccine rollout
BY
Michelle Fay Cortez
,
Anna Edney
, and others
International
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
BY
Michelle Fay Cortez
,
Riley Griffin
, and others
Health
Study: COVID-19 antibodies don’t last very long, raising risk of lost immunity
BY
Michelle Fay Cortez
,
Niclas Rolander
, and others
Health
As hospitalizations hit new records and states impose quarantines, businesses reconsider reopening
BY
Margaret Newkirk
,
Jonathan Levin
, and others
Load More